Purdue Hints At Large Acquisition In Coming Weeks
Executive Summary
Purdue Pharma's business development director and head of medical affairs talk to Scrip about the company's hunt for new drugs to add to its portfolio outside of the opioid pain therapy space and how it is preparing for generic erosion and increasing pricing pressures in the US.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.